Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB(1) cannabinoid receptor ligands and potential antagonists: synthesis, lipophilicity, affinity, and molecular modeling.

Details

Serval ID
serval:BIB_22817
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB(1) cannabinoid receptor ligands and potential antagonists: synthesis, lipophilicity, affinity, and molecular modeling.
Journal
Journal of Medicinal Chemistry
Author(s)
Ooms F., Wouters J., Oscari O., Happaerts T., Bouchard G., Carrupt P.A., Testa B., Lambert D.M.
ISSN
0022-2623[print], 0022-2623[linking]
Publication state
Published
Issued date
2002
Volume
45
Number
9
Pages
1748-1756
Language
english
Notes
Publication types: In Vitro ; Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Abstract
A set of 29 3-alkyl 5-arylimidazolidinediones (hydantoins) with affinity for the human cannabinoid CB(1) receptor was studied for their lipophilicity and conformational properties in order to delineate a pharmacophore. These molecules constitute a new template for cannabinoid receptor recognition, since (a) their structure differs from that of classical cannabinoid ligands and (b) antagonism is the mechanism of action of at least three compounds (20, 21, and 23). Indeed, in the [(35)S]-GTP gamma S binding assay using rat cerebellum homogenates, they behave as antagonists without any inverse agonism component. Using a set of selected compounds, experimental lipophilicity was measured by RP-HPLC and calculated by a fragmental method (CLOGP) and a conformation-dependent method (CLIP based on the molecular lipophilicity potential). These approaches revealed two models which differentiate the binding mode of nonpolar and polar hydantoins and which could explain, at least for compounds 20, 21, and 23, the mechanism of action of this new family of cannabinoid ligands.
Keywords
Animals, Binding, Competitive, CHO Cells, Cannabinoids/metabolism, Cerebellum/metabolism, Chromatography, High Pressure Liquid, Cricetinae, Crystallography, X-Ray, Humans, Hydantoins/chemical synthesis, Hydantoins/chemistry, Ligands, Models, Molecular, Molecular Conformation, Radioligand Assay, Rats, Receptors, Cannabinoid, Receptors, Drug/antagonists &amp, inhibitors, Receptors, Drug/chemistry, Structure-Activity Relationship
Pubmed
Create date
19/11/2007 9:47
Last modification date
20/08/2019 12:59
Usage data